HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jah-Yao Liu Selected Research

Disorders of Sex Development (Intersexuality)

6/2009Boy born after gender preselection following successive gestational androgen excess of maternal luteoma and female disorders of sex development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jah-Yao Liu Research Topics

Disease

14Neoplasms (Cancer)
11/2016 - 08/2003
4Breast Neoplasms (Breast Cancer)
09/2012 - 09/2007
3Ovarian Neoplasms (Ovarian Cancer)
11/2016 - 08/2003
3Pain (Aches)
05/2009 - 11/2006
2Mouth Neoplasms (Oral Cancer)
11/2011 - 01/2010
2Luteoma
06/2009 - 08/2005
2Dysmenorrhea (Menstrual Pain)
05/2009 - 08/2007
1Endometrial Neoplasms (Endometrial Cancer)
03/2021
1Lung Injury
10/2019
1Acidosis
12/2011
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2009
1Disorders of Sex Development (Intersexuality)
06/2009
1XX Disorders of Sex Development 46 (Female Pseudohermaphroditism)
06/2009
1Anemia
05/2009
1Colorectal Neoplasms (Colorectal Cancer)
12/2008
1Carcinogenesis
12/2008
1Unconsciousness (Loss of Consciousness)
06/2008
1Prostatic Neoplasms (Prostate Cancer)
02/2008
1Carcinoma (Carcinomatosis)
09/2007
1Solitary Fibrous Tumors
12/2006
1Postoperative Pain
11/2006
1Flatulence
11/2006
1Ischemia
10/2006
1Myoma
01/2006
1Hypertrophy
08/2005
1Hyperandrogenism
08/2005
1Virilism (Virilization)
08/2005
1Leiomyoma (Uterine Fibroids)
04/2005
1Infections
04/2005
1Wound Infection (Wound Infections)
04/2005
1Precocious Puberty
03/2004
1Hemorrhage
05/2002
1Hemolysis
05/2002

Drug/Important Bio-Agent (IBA)

3Paclitaxel (Taxol)FDA LinkGeneric
01/2013 - 08/2003
3Proteins (Proteins, Gene)FDA Link
01/2012 - 08/2003
2Antineoplastic Agents (Antineoplastics)IBA
01/2013 - 01/2012
2AlkaloidsIBA
09/2012 - 08/2011
2BerberineIBA
09/2012 - 08/2011
2Pharmaceutical PreparationsIBA
11/2011 - 01/2010
2Interferon-gamma (Interferon, gamma)IBA
01/2010 - 02/2008
2AndrogensIBA
06/2009 - 08/2005
2si-wu-tangIBA
05/2009 - 08/2007
1Ethanol (Ethyl Alcohol)IBA
03/2021
1Complement Membrane Attack Complex (Membrane Attack Complex)IBA
10/2019
1Phosphoinositide Phospholipase CIBA
10/2019
1Complement System Proteins (Complement)IBA
10/2019
1Cisplatin (Platino)FDA LinkGeneric
01/2013
1isoquinolineIBA
09/2012
1triptolideIBA
01/2012
1CatalaseIBA
12/2011
1AcidsIBA
12/2011
1Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA
12/2011
1Fomepizole (Antizol)FDA LinkGeneric
12/2011
1Phosphotransferases (Kinase)IBA
11/2011
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
11/2011
1Small Interfering RNA (siRNA)IBA
11/2011
1Biomarkers (Surrogate Marker)IBA
11/2011
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2010
1TeaIBA
01/2010
1ErbB Receptors (EGF Receptor)IBA
08/2009
1Methanol (Carbinol)IBA
08/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2009
1Trypan BlueFDA Link
12/2008
1Therapeutic UsesIBA
12/2008
1Cyclin AIBA
12/2008
1Sevoflurane (Ultane)FDA LinkGeneric
06/2008
1Oxygen (Dioxygen)IBA
06/2008
1Fentanyl (Sublimaze)FDA LinkGeneric
06/2008
1Oncogene Proteins (Oncogene Protein)IBA
02/2008
1Superoxide DismutaseIBA
09/2007
1Coloring Agents (Dyes)IBA
12/2006
1Morphine (MS Contin)FDA LinkGeneric
11/2006
1Analgesics (Analgesic Drugs)IBA
11/2006
1KetorolacIBA
11/2006
1N-Methylaspartate (NMDA)IBA
11/2006
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
11/2006
1Dextromethorphan (Racemethorphan)FDA LinkGeneric
11/2006
1Oxytocin (Pitocin)FDA LinkGeneric
01/2006
1Misoprostol (Cytotec)FDA LinkGeneric
01/2006
1Cefazolin (Ancef)FDA LinkGeneric
04/2005
1GonadotropinsIBA
03/2004
1Type II DNA Topoisomerases (Topoisomerase II)IBA
08/2003
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2003
1Etoposide (VP 16)FDA LinkGeneric
08/2003
1RHO(D) antibody (anti-D)IBA
05/2002
1Immunoglobulins (Immunoglobulin)IBA
05/2002

Therapy/Procedure

5Therapeutics
11/2016 - 08/2007
1Aftercare (After-Treatment)
11/2011
1Chinese Traditional Medicine (Traditional Chinese Medicine)
05/2009
1Laparotomy
12/2006
1Patient-Controlled Analgesia (Analgesia, Patient Controlled)
11/2006
1Vaginal Hysterectomy
11/2006
1Analgesia
11/2006
1Bed Rest (Bedrest)
11/2006
1Autologous Transplantation
10/2006
1Transplantation
10/2006
1Surgical Instruments (Clip)
04/2005
1Hysterectomy
04/2005
1Phototherapy (Light Therapy)
05/2002